NCT01870245View on ClinicalTrials.gov

A Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 30, 2013

Conditions
Healthy Volunteer
Interventions
DRUG

ACHN-975

Intravenous multiple dose

DRUG

placebo

Intravenous multiple dose

Trial Locations (1)

66211

Investigational Site, Overland Park

Sponsors

Lead Sponsor

Achaogen, Inc.
All Listed Sponsors
lead

Achaogen, Inc.

INDUSTRY

NCT01870245 - A Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers | Biotech Hunter | Biotech Hunter